These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21567112)

  • 1. Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series.
    Ng SY; Chin KJ; Kwek TK
    Intensive Care Med; 2011 Aug; 37(8):1285-9. PubMed ID: 21567112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening hyperkalaemia following therapeutic barbiturate coma.
    Cairns CJ; Thomas B; Fletcher S; Parr MJ; Finfer SR
    Intensive Care Med; 2002 Sep; 28(9):1357-60. PubMed ID: 12209290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypokalaemia with severe rebound hyperkalaemia after therapeutic barbiturate coma.
    Neil MJ; Dale MC
    Anesth Analg; 2009 Jun; 108(6):1867-8. PubMed ID: 19448214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypokalemia and rebound hyperkalemia during barbiturate coma in patients with severe traumatic brain injury.
    Aytuluk HG; Topcu H
    Neurocirugia (Astur : Engl Ed); 2020; 31(5):216-222. PubMed ID: 32146086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life-Threatening Dyskalaemia after Barbiturate Coma Therapy: The Strategy of Management.
    Tat YB; Hassan WMNW; Chuen TY; Ghani ARI
    Malays J Med Sci; 2017 Mar; 24(2):100-105. PubMed ID: 28894410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barbiturate-induced dyskalaemia in patients with traumatic brain injury patient.
    Theodore D; Mahanes D
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30996067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in white blood cell counts after thiopentone barbiturate therapy for refractory intracranial hypertension: A common complication.
    Ng SY; Chin KJ; Kwek TK
    J Neurosci Rural Pract; 2013 Aug; 4(Suppl 1):S31-4. PubMed ID: 24174796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methohexital for treatment of intracranial hypertension].
    Hilbert P; Kern BC; Langer S; Jakubetz J; Stuttmann R
    Anaesthesist; 2011 Sep; 60(9):819-26. PubMed ID: 21509574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients.
    Stover JF; Pleines UE; Morganti-Kossmann MC; Stocker R; Kossmann T
    Crit Care Med; 1999 Jul; 27(7):1351-7. PubMed ID: 10446831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal effects of barbiturate coma on intracranial pressure and compensatory reserve in children with traumatic brain injury.
    Velle F; Lewén A; Howells T; Nilsson P; Enblad P
    Acta Neurochir (Wien); 2021 Feb; 163(2):489-498. PubMed ID: 33341913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential occurrence of life-threatening hypokalemia and rebound hyperkalemia associated with barbiturate coma therapy.
    Jung JY; Lee C; Ro H; Kim HS; Joo KW; Kim Y; Ahn C; Han JS; Kim S; Oh KH
    Clin Nephrol; 2009 Mar; 71(3):333-7. PubMed ID: 19281748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barbiturate infusion for intractable intracranial hypertension and its effect on brain oxygenation.
    Chen HI; Malhotra NR; Oddo M; Heuer GG; Levine JM; LeRoux PD
    Neurosurgery; 2008 Nov; 63(5):880-6; discussion 886-7. PubMed ID: 19005378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of barbiturate coma on adrenal response in patients with traumatic brain injury.
    Llompart-Pou JA; Pérez-Bárcena J; Raurich JM; Burguera B; Ayestarán JI; Abadal JM; Homar J; Ibáñez J
    J Endocrinol Invest; 2007 May; 30(5):393-8. PubMed ID: 17598971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of decompressive craniectomy versus barbiturate coma for refractory intracranial hypertension following traumatic brain injury.
    Alali AS; Naimark DM; Wilson JR; Fowler RA; Scales DC; Golan E; Mainprize TG; Ray JG; Nathens AB
    Crit Care Med; 2014 Oct; 42(10):2235-43. PubMed ID: 25054675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury.
    Stover JF; Stocker R
    Eur J Clin Pharmacol; 1998 Sep; 54(7):529-34. PubMed ID: 9832294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory hypokalemia during barbiturate coma therapy used for treating refractory intracranial hypertension in traumatic brain injury.
    Wan Hassan WM; Najid NM; Muslim HS; Izaini Ghani AR
    Asian J Neurosurg; 2015; 10(1):59. PubMed ID: 25767595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barbiturate therapy for patients with refractory intracranial hypertension following severe traumatic brain injury: its effects on tissue oxygenation, brain temperature and autoregulation.
    Thorat JD; Wang EC; Lee KK; Seow WT; Ng I
    J Clin Neurosci; 2008 Feb; 15(2):143-8. PubMed ID: 17997313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentobarbital Induced Hypokalemia: A Worrying Sequela.
    Awad M; Bonitz J; Pratt A
    Int J Surg Case Rep; 2020; 71():323-326. PubMed ID: 32492644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged thiopentone infusion for neurosurgical emergencies: usefulness of therapeutic drug monitoring.
    Cordato DJ; Herkes GK; Mather LE; Gross AS; Finfer S; Morgan MK
    Anaesth Intensive Care; 2001 Aug; 29(4):339-48. PubMed ID: 11512643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial.
    Pérez-Bárcena J; Llompart-Pou JA; Homar J; Abadal JM; Raurich JM; Frontera G; Brell M; Ibáñez J; Ibáñez J
    Crit Care; 2008; 12(4):R112. PubMed ID: 18759980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.